SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

GenMark Diagnostics shares are trading higher after the company announced it submitted an emergency use authorization for its eSensor SARS-Coronavirus 2 test.

Benzinga · 08/17/2020 12:24